BeStock  
Stocks › Biotechnology › GERN

Geron GERN

US equityMarket cap rank #3527Biotechnology
$0.87 −$0.04 (-4.63%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $0.89 +2.45%
Open$0.89
Prev close$0.91
Day range$0.86 – $0.93
Volume13.83M
Market cap$560.94M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-12.1x
CheapRich

Near the bottom of its 5-year range · 18th percentile, 5-year average -8.6x

Price / book2.7x
CheapRich

Near the bottom of its 5-year range · 5th percentile, 5-year average 5.5x

#3618 of 5329 stocks by PB (1 = cheapest)

Price / sales2.9x
CheapRich

Near the bottom of its 5-year range · 0th percentile, 5-year average 1,373.6x

#3069 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-16x-11x-7x-2xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$1.09
Price vs. fair value-20.1%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.75 – 5.52 5% (cheaper than usual) #3618 of 5329 (1 = cheapest)
PE -12.09 20.54 -8.56 18% (cheaper than usual) –
PS 2.86 1.99 1,373.59 0% (cheaper than usual) #3069 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on GERN.

Sign in to join the discussion.

Scroll to Top